Johnson Matthey recently expanded its Cambridge facility to add process development and small-scale manufacturing capabilities. Brian Fairley and Antonio Zanotti-Gerosa explain how this will benefit pharmaceutical manufacturing
Johnson Matthey’s facility in Cambridge, UK, is a recognised centre of excellence for catalyst discovery, chiral technologies and process identification. Earlier this year the company expanded the facility to add process development and small-scale manufacturing capabilities to the site, which also now incorporates the company’s recently acquired Pharmorphix solid form services business.